According to Binsaleh et al., PCa patients with COVID-19 had higher levels of proinflammatory cytokines (IFN-γ, TNF-α, and IL-6) than non-COVID-19 PCa patients, suggesting that these inflammatory cytokines may have caused inflammation in COVID-19 PCa patients [71]. The gene discussed is TNF; the disease is COVID-19.